Literature DB >> 11959433

Oral colonization and immune responses to Streptococcus gordonii expressing a pertussis toxin S1 fragment in mice.

Song F Lee1, S A Halperin, H Wang, A MacArthur.   

Abstract

The ability of a recombinant Streptococcus gordonii RJM4 expressing the N-terminal 179-amino acid fragment of S1 subunit of pertussis toxin (PT) as a SpaP/S1 fusion protein was tested for oral colonization and immunogenicity in BALB/c mice. Following two consecutive oral inoculations, 100% of the mice were colonized by the recombinant strains for up to 9 weeks and >60% of the animals still retained the strains after 19 weeks. RJM4 recovered from the animals continued to express the SpaP/S1 fusion protein indicating the stability of the fusion gene in vivo. Secretory (S) IgA antibody against PT could be detected in saliva from RJM4-colonized mice but not from the control groups of mice. SIgA against SpaP was also detected in saliva from the RJM4-inoculated and the S. gordonii SL3 (control)-inoculated mice. Serum antibodies against PT and SpaP were not detected in these animals. In conclusion, long-term oral colonization of BALB/c mice with our recombinant S. gordonii was established and the colonization elicited mucosal antibodies against PT and SpaP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959433     DOI: 10.1111/j.1574-6968.2002.tb11078.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  17 in total

1.  Expression of a C terminally truncated form of pertussis toxin S1 subunit effectively induces protection against pertussis toxin following DNA-based immunization.

Authors:  Kazunari Kamachi; Yoshichika Arakawa
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

2.  Role of the cell wall microenvironment in expression of a heterologous SpaP-S1 fusion protein by Streptococcus gordonii.

Authors:  Elisabeth Davis; Dustin Kennedy; Scott A Halperin; Song F Lee
Journal:  Appl Environ Microbiol       Date:  2010-12-30       Impact factor: 4.792

3.  Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine.

Authors:  Karen L Kotloff; Steven S Wasserman; Kevin F Jones; Sofie Livio; Dennis E Hruby; Christine A Franke; Vincent A Fischetti
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Expression of a functional single-chain variable-fragment antibody against complement receptor 1 in Streptococcus gordonii.

Authors:  Jennifer B Knight; Scott A Halperin; Kenneth A West; Song F Lee
Journal:  Clin Vaccine Immunol       Date:  2008-04-02

5.  Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii.

Authors:  Song F Lee; Scott A Halperin; Jennifer B Knight; Aaron Tait
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

6.  Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordonii.

Authors:  Chiang W Lee; Song F Lee; Scott A Halperin
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

7.  Functional analysis of paralogous thiol-disulfide oxidoreductases in Streptococcus gordonii.

Authors:  Lauren Davey; Crystal K W Ng; Scott A Halperin; Song F Lee
Journal:  J Biol Chem       Date:  2013-04-24       Impact factor: 5.157

8.  Construction and characterization of single-chain variable fragment antibodies directed against the Bordetella pertussis surface adhesins filamentous hemagglutinin and pertactin.

Authors:  Ahmad H Hussein; Elisabeth M Davis; Scott A Halperin; Song F Lee
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

9.  Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.

Authors:  Praveen Mannam; Kevin F Jones; Bruce L Geller
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  Role of D-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunity.

Authors:  Karenn G Chan; Matt Mayer; Elisabeth M Davis; Scott A Halperin; Tong-Jun Lin; Song F Lee
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.